Skip to content
Home/Companies/MedTech/Biomodex

Biomodex

MedTech·France·Exited 2023·Held 7yr
Entry
2016
Hold
7yr
Exit
2023

Who owns Biomodex?

Biomodex was owned by LBO France through LBO France Venture (2016 vintage) from 2016 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

LBO France
Investor
LBO France
LBO France Venture · 2016 · VC

Key facts

HQFrance
SectorMedTech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from LBO France Venture

Other portfolio companies in the same fund.

12.5
Active
TMTFrance· 2025
Antidote
Active
HealthTechUK· 2025
Mediaire
Active
HealthTechGermany· 2025
Siteflow
Siteflow
Active
TMTFrance· 2025
Colpad
Active
HealthcareFrance· 2024
Vestalis
Vestalis
Active
HealthcareFrance· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Biomodex

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Biomodex?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Biomodex.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue